BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21795425)

  • 1. Genetic variation in myeloperoxidase modifies the association of serum α-tocopherol with aggressive prostate cancer among current smokers.
    Cheng TY; Barnett MJ; Kristal AR; Ambrosone CB; King IB; Thornquist MD; Goodman GE; Neuhouser ML
    J Nutr; 2011 Sep; 141(9):1731-7. PubMed ID: 21795425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: a gene-nutrient interaction in the carotene and retinol efficacy trial.
    Cheng TY; King IB; Barnett MJ; Ambrosone CB; Thornquist MD; Goodman GE; Neuhouser ML
    Am J Epidemiol; 2013 May; 177(10):1106-17. PubMed ID: 23535901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.
    Weinstein SJ; Peters U; Ahn J; Friesen MD; Riboli E; Hayes RB; Albanes D
    PLoS One; 2012; 7(7):e40204. PubMed ID: 22792240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE; Schaffer S; Omenn GS; Chen C; King I
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
    Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
    BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort.
    Choi JY; Neuhouser ML; Barnett MJ; Hong CC; Kristal AR; Thornquist MD; King IB; Goodman GE; Ambrosone CB
    Carcinogenesis; 2008 May; 29(5):964-70. PubMed ID: 18296681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
    Bauer SR; Richman EL; Sosa E; Weinberg V; Song X; Witte JS; Carroll PR; Chan JM
    Prostate; 2013 Dec; 73(16):1786-95. PubMed ID: 24038157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.
    Key TJ; Appleby PN; Travis RC; Albanes D; Alberg AJ; Barricarte A; Black A; Boeing H; Bueno-de-Mesquita HB; Chan JM; Chen C; Cook MB; Donovan JL; Galan P; Gilbert R; Giles GG; Giovannucci E; Goodman GE; Goodman PJ; Gunter MJ; Hamdy FC; Heliövaara M; Helzlsouer KJ; Henderson BE; Hercberg S; Hoffman-Bolton J; Hoover RN; Johansson M; Khaw KT; King IB; Knekt P; Kolonel LN; Le Marchand L; Männistö S; Martin RM; Meyer HE; Mondul AM; Moy KA; Neal DE; Neuhouser ML; Palli D; Platz EA; Pouchieu C; Rissanen H; Schenk JM; Severi G; Stampfer MJ; Tjønneland A; Touvier M; Trichopoulou A; Weinstein SJ; Ziegler RG; Zhou CK; Allen NE;
    Am J Clin Nutr; 2015 Nov; 102(5):1142-57. PubMed ID: 26447150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.
    Weinstein SJ; Wright ME; Pietinen P; King I; Tan C; Taylor PR; Virtamo J; Albanes D
    J Natl Cancer Inst; 2005 Mar; 97(5):396-9. PubMed ID: 15741576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.
    Choi JY; Neuhouser ML; Barnett M; Hudson M; Kristal AR; Thornquist M; King IB; Goodman GE; Ambrosone CB
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1115-20. PubMed ID: 17548672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
    Li H; Kantoff PW; Giovannucci E; Leitzmann MF; Gaziano JM; Stampfer MJ; Ma J
    Cancer Res; 2005 Mar; 65(6):2498-504. PubMed ID: 15781667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).
    Woodson K; Tangrea JA; Lehman TA; Modali R; Taylor KM; Snyder K; Taylor PR; Virtamo J; Albanes D
    Cancer Causes Control; 2003 Aug; 14(6):513-8. PubMed ID: 12948282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival.
    Watters JL; Gail MH; Weinstein SJ; Virtamo J; Albanes D
    Cancer Res; 2009 May; 69(9):3833-41. PubMed ID: 19383902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk.
    Mondul AM; Rohrmann S; Menke A; Feinleib M; Nelson WG; Platz EA; Albanes D
    Cancer Causes Control; 2011 Jun; 22(6):827-36. PubMed ID: 21424597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E intake, alpha-tocopherol status, and pancreatic cancer in a cohort of male smokers.
    Stolzenberg-Solomon RZ; Sheffler-Collins S; Weinstein S; Garabrant DH; Mannisto S; Taylor P; Virtamo J; Albanes D
    Am J Clin Nutr; 2009 Feb; 89(2):584-91. PubMed ID: 19116326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk.
    Mikhak B; Hunter DJ; Spiegelman D; Platz EA; Wu K; Erdman JW; Giovannucci E
    Carcinogenesis; 2008 Dec; 29(12):2335-40. PubMed ID: 18784358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and dietary vitamin E in relation to prostate cancer risk.
    Weinstein SJ; Wright ME; Lawson KA; Snyder K; Männistö S; Taylor PR; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1253-9. PubMed ID: 17548693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population.
    Arslan S; Pinarbasi H; Silig Y
    Mol Med Rep; 2011; 4(1):87-92. PubMed ID: 21461569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood α-tocopherol, γ-tocopherol levels and risk of prostate cancer: a meta-analysis of prospective studies.
    Cui R; Liu ZQ; Xu Q
    PLoS One; 2014; 9(3):e93044. PubMed ID: 24667740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum phytanic and pristanic acid levels and prostate cancer risk in Finnish smokers.
    Wright ME; Albanes D; Moser AB; Weinstein SJ; Snyder K; Männistö S; Gann PH
    Cancer Med; 2014 Dec; 3(6):1562-9. PubMed ID: 25132681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.